Adicet Bio, Inc

Adicet Bio, Inc. is a leading biotechnology research company dedicated to developing innovative gamma-delta T cell therapies for patients battling autoimmune diseases and cancer. Adicet Bio, Inc. is committed to pioneering advancements in cell therapy, focusing on creating transformative treatments that can significantly improve patient outcomes.

Adicet Bio, Inc. leverages the unique properties of gamma-delta T cells, which preferentially target tissues and deplete B cells, potentially resetting the immune system in autoimmune disease patients. These cells also offer multiple pathways to target and eliminate cancer cells, including those in solid tumors. By utilizing allogeneic cells from donors, Adicet Bio, Inc. aims to provide readily available, off-the-shelf therapies that can be administered on demand.

Adicet Bio, Inc. continues to attract and retain top talent in the biopharmaceutical and cell therapy sectors. The company provides a comprehensive benefits package, including competitive financial compensation, extensive health plans, generous paid time off, educational reimbursement, and access to state-of-the-art facilities. To the manager of Adicet Bio, Inc., we invite you to create a customized and exclusive company showcase and product listing on our platform to further highlight your groundbreaking work.